RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00050348.xml
PDF herunterladen
CC BY 4.0 · Indian J Med Paediatr Oncol 2023; 44(02): 207-228
DOI: 10.1055/s-0042-1760326
DOI: 10.1055/s-0042-1760326
Review Article
Imaging Recommendations for Diagnosis, Staging, and Management of Breast Cancer
Authors
Abstract
In a rapidly evolving world, with a steep rise in breast cancer incidence, there has been many advances in imaging and therapeutic options of breast cancer care. In this review article, we are trying to cover imaging guideline for cancer detection and their therapeutic options. These help in the reduction of morbidity and mortality.
Publikationsverlauf
Artikel online veröffentlicht:
04. Mai 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1
Sung H,
Ferlay J,
Siegel RL.
et al.
Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide
for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
Reference Ris Wihthout Link
- 2 Global Cancer Observatory. Accessed March 18, 2022, at: https://gco.iarc.fr/
- 3 Lima SM, Kehm RD, Terry MB. Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns. EClinicalMedicine 2021; 38: 100985
- 4 Mathur P, Sathishkumar K, Chaturvedi M. et al; ICMR-NCDIR-NCRP Investigator Group. Cancer statistics, 2020: report from National Cancer Registry Programme, India. JCO Glob Oncol 2020; 6 (06) 1063-1075
- 5 Wu S, Zhu W, Thompson P, Hannun YA. Evaluating intrinsic and non-intrinsic cancer risk factors. Nat Commun 2018; 9 (01) 3490
- 6 Institute of Medicine (US) Committee on Cancer Control in Low- and Middle-Income Countries. Cancer Control Opportunities in Low- and Middle-Income Countries. Cancer Control Opportunity Low-Middle-Income Countries. in: Sloan FA, Gelband H. eds. Washington, DC: National Academies Press; 2007
- 7 What Are the Risk Factors for Breast Cancer? | CDC. Accessed March 18, 2022, at: https://www.cdc.gov/cancer/breast/basic_info/risk_factors.htm
- 8 Morris KT, Pommier RF, Morris A. et al. Usefulness of the triple test score for palpable breast masses; discussion 1012-3. Arch Surg 2001; 136 (09) 1008-1012
- 9 Hortobagyi GN, Connolly JL, D'Orsi CJ, Yang WT. Breast. in: Amin MB, Edge S, Greene F. et al., eds; American Joint Committee on Cancer 8th ed.. Springer: AJCC cancer staging manual; 2017: 589-636
- 10 AJCC 8th edition staging; 2018, at: Accessed on 12th Jan 2023 http://www.breastsurgeonsweb.com/wp-content/uploads/downloads/2020/10/AJCC-Breast-Cancer-Staging-System.pdf
- 11 Mainiero MB, Moy L, Baron P. et al; Expert Panel on Breast Imaging. ACR Appropriateness Criteria® Breast Cancer Screening. J Am Coll Radiol 2017; 14 (11S): S383-S390
- 12 Chakrabarthi S, Panwar S, Singh T. et al. Best Practice Guidelines for Breast Imaging, Breast Imaging Society, India. Ann Natl Acad Med Sci 2022; 58 (Suppl. 02) 060-068
- 13 Massat NJ, Dibden A, Parmar D, Cuzick J, Sasieni PD, Duffy SW. Impact of screening on breast cancer mortality: the UK program 20 years on. Cancer Epidemiol Biomarkers Prev 2016; 25 (03) 455-462
- 14 Lee CH, Dershaw DD, Kopans D. et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 2010; 7 (01) 18-27
- 15 Protocols for surveillance of women at very high risk of developing breast cancer - GOV.UK. Accessed March 18, 2022, at: https://www.gov.uk/government/publications/breast-screening-higher-risk-women-surveillance-protocols/protocols-for-surveillance-of-women-at-higher-risk-of-developing-breast-cancer
- 16 Mendelson EB. Problem-solving ultrasound. Radiol Clin North Am 2004; 42 (05) 909-918 , vii
- 17 Guidance on screening and symptomatic breast imaging, Fourth edition | The Royal College of Radiologists. Accessed March 18, 2022, at: https://www.rcr.ac.uk/publication/guidance-screening-and-symptomatic-breast-imaging-fourth-edition
- 18 Sharpe Jr RE, Venkataraman S, Phillips J. et al. Increased cancer detection rate and variations in the recall rate resulting from implementation of 3D digital breast tomosynthesis into a population-based screening program. radiology. Radiology 2016; 278 (03) 698-706
- 19 D'Orsi CJ, Sickles EA, Mendelson EB. et al. ACR BI-RADS Mammography. In: ACR BI-RADS Atlas, Breast Imaging Reporting and Data System. 5th ed.. Reston, VA: American College of Radiology; 2013: 134-136
- 20 Lee S, Jung Y, Bae Y. Synchronous BI-RADS category 3 lesions on preoperative ultrasonography in patients with breast cancer: is short-term follow-up appropriate?. J Breast Cancer 2015; 18 (02) 181-186
- 21 Kim SJ, Ko EY, Shin JH. et al. Application of sonographic BI-RADS to synchronous breast nodules detected in patients with breast cancer. AJR Am J Roentgenol 2008; 191 (03) 653-658
- 22 Indian Council of Medical Research, Government of India. ICMR Subcommittee on Breast Cancer. Consensus document for management of breast cancer, 2016. March 19, 2022, at: http://cancerindia.org.in/wp-content/uploads/2017/11/Breast_Cancer.pdf. - Google Search
- 23 Canadian Association of Radiologists. CAR Practice guidelines and technical standards for breast imaging and intervention. Approved on September 29, 2012; modified on September 17, 2016. Accessed September 2021, at: https://car.ca/wp-content/uploads/Breast-Imaging-and-Intervention-2016.pdf
- 24 American College of Radiology. ACR practice parameter for the performance of ultrasound-guided percutaneous breast interventional procedures, Revised 2021 (Resolution 31). Accessed March 19, 2022, at: https://www.acr.org/-/media/acr/files/practice-parameters/us-guidedbreast.pdf. – Google Search
- 25 ACR practice parameter for the performance of magnetic resonance imaging–guided breast interventional procedures, Revised 2021 (Resolution 29). Accessed March 19, 2022, at: https://www.acr.org/-/media/ACR/Files/Practice-Parameters/MR-Guided-Breast.pdf – Google Search
- 26 Chakrabarthi S. Stereotactic breast biopsy: a review & applicability in the Indian context. Indian J Med Res 2021; 154 (02) 237-247
- 27 Ghaderi KF, Phillips J, Perry H, Lotfi P, Mehta TS. Contrast-enhanced mammography: current applications and future directions. Radiographics 2019; 39 (07) 1907-1920
- 28 Harbeck N, Penault-Llorca F, Cortes J. et al. Breast cancer. Nat Rev Dis Primers 2019; 5 (01) 66
- 29 Taneja S, Evans AJ, Rakha EA, Green AR, Ball G, Ellis IO. The mammographic correlations of a new immunohistochemical classification of invasive breast cancer. Clin Radiol 2008; 63 (11) 1228-1235
- 30 Boisserie-Lacroix M, Hurtevent-Labrot G, Ferron S, Lippa N, Bonnefoi H, Mac Grogan G. Correlation between imaging and molecular classification of breast cancers. Diagn Interv Imaging 2013; 94 (11) 1069-1080
- 31 The American College of Surgeons. Part IX - Breast, AJCC cancer staging manual, 8th edition, updated May 25 2018. Accessed March 19, 2022, at: http://www.breastsurgeonsweb.com/wp-content/uploads/downloads/2020/10/AJCC-Breast-Cancer-Staging-System.pdf - Google Search
- 32 National Comprehensive Cancer Network. Breast Cancer Version 4.2022 — June 21, 2022. Accessed November 10, 2022, at: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
- 33 National Cancer Grid. India. National Cancer Grid Breast Cancer Management Guidelines, September, 2019. Accessed March 19, 2022, at: https://tmc.gov.in/ncg/docs/PDF/DraftGuidelines/Breast/NCG_guidelines_2019_Breast.pdf - Google Search
- 34 Algorithm for Breast Imaging - Breast Imaging Society. India. Accessed March 19, 2022, at: https://www.bisi.co.in/guidelines/algorithm-for-breast-imaging/
- 35 Kalli S, Semine A, Cohen S, Naber SP, Makim SS, Bahl M. American Joint Committee on Cancer's Staging System for breast cancer, eighth edition: what the radiologist needs to know. Radiographics 2018; 38 (07) 1921-1933
- 36 Teichgraeber DC, Guirguis MS, Whitman GJ. Breast cancer staging: Updates in the AJCC cancer staging manual, 8th edition, and current challenges for radiologists, from the AJR special series on cancer staging. Am J Roentgenol 2021; 217 (02) 278-290
- 37 Chang JM, Leung JWT, Moy L, Ha SM, Moon WK. Axillary nodal evaluation in breast cancer: state of the art. Radiology 2020; 295 (03) 500-515
- 38 van Nijnatten TJA, Jochelson MS, Lobbes MBI. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: overview of current evidence per imaging modality. Eur J Radiol 2022; 152: 110334
- 39 Pesapane F, Downey K, Rotili A, Cassano E, Koh D-M. Imaging diagnosis of metastatic breast cancer. Insights Imaging 2020; 11 (01) 79
- 40 Barra FR, Sobrinho AB, Barra RR. et al. Contrast-enhanced mammography (CEM) for detecting residual disease after neoadjuvant chemotherapy: a comparison with breast magnetic resonance imaging (MRI). BioMed Res Int 2018; 2018: 8531916
- 41 Holmes D, Colfry A, Czerniecki B. et al. Performance and practice guideline for the use of neoadjuvant systemic therapy in the management of breast cancer. Ann Surg Oncol 2015; 22 (10) 3184-3190
- 42 Fowler AM, Mankoff DA, Joe BN. Imaging neoadjuvant therapy response in breast cancer. Radiology 2017; 285 (02) 358-375
- 43 Riedl CC, Pinker K, Ulaner GA. et al. Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer. Eur J Nucl Med Mol Imaging 2017; 44 (09) 1428-1437
- 44 Dose Schwarz J, Bader M, Jenicke L, Hemminger G, Jänicke F, Avril N. Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET. J Nucl Med 2005; 46 (07) 1144-1150
- 45 Janssen NNY, Nijkamp J, Alderliesten T. et al. Radioactive seed localization in breast cancer treatment. Br J Surg 2016; 103 (01) 70-80
- 46 Garzotto F, Comoretto RI, Michieletto S. et al. Preoperative non-palpable breast lesion localization, innovative techniques and clinical outcomes in surgical practice: a systematic review and meta-analysis. Breast 2021; 58: 93-105
- 47 Flowers CI, Mooney BP, Drukteinis JS. Clinical and imaging surveillance following breast cancer diagnosis. Am Soc Clin Oncol Educ Book 2012; •••: 59-64
- 48 Brennan S, Liberman L, Dershaw DD, Morris E. Breast MRI screening of women with a personal history of breast cancer. AJR Am J Roentgenol 2010; 195 (02) 510-516
- 49 Kerridge WD, Kryvenko ON, Thompson A, Shah BA. Fat necrosis of the breast: a pictorial review of the mammographic, ultrasound, CT, and MRI findings with histopathologic correlation. Radiol Res Pract 2015; 2015: 613139
- 50 Schrijver WAME, Suijkerbuijk KPM, van Gils CH, van der Wall E, Moelans CB, van Diest PJ. Receptor conversion in distant breast cancer metastases: a systematic review and meta-analysis. J Natl Cancer Inst 2018; 110 (06) 568-580
- 51 Golan O, Amitai Y, Barnea Y, Menes TS. Yield of surveillance magnetic resonance imaging after bilateral mastectomy and reconstruction: a retrospective cohort study. Breast Cancer Res Treat 2019; 174 (02) 463-468
- 52 Osei EK, Faulkner K. Fetal doses from radiological examinations. Br J Radiol 1999; 72 (860) 773-780
- 53 Sechopoulos I, Suryanarayanan S, Vedantham S, D'Orsi CJ, Karellas A. Radiation dose to organs and tissues from mammography: Monte Carlo and phantom study. Radiology 2008; 246 (02) 434-443
- 54 Committee Opinion No. Committee opinion no. 723: guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol 2017; 130 (04) e210-e216
- 55 Özmen V. Paradigm shift from Halstedian radical mastectomy to personalized medicine. J Breast Health 2017; 13 (02) 50-53
- 56 Parmar V, Koppiker CB, Dixit S. Breast conservation surgery & oncoplasty in India – current scenario. Indian J Med Res 2021; 154 (02) 221-228
- 57 Berruti A, Amoroso V, Gallo F. et al. Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies. J Clin Oncol 2014; 32 (34) 3883-3891
- 58 Burstein HJ, Lacchetti C, Anderson H. et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol 2019; 37 (05) 423-438
- 59 Schmid P, Cortes J, Pusztai L. et al; KEYNOTE-522 Investigators. Pembrolizumab for early triple-negative breast cancer. N Engl J Med 2020; 382 (09) 810-821
- 60 Emens LA, Adams S, Barrios CH. et al. First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis. Ann Oncol 2021; 32 (08) 983-993
- 61 Masuda N, Lee S-J, Ohtani S. et al. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med 2017; 376: 2147-2159
- 62 Abraham G, Noronha V, Rajappa S. et al. The clinical utility and safety of short-course immune checkpoint inhibitors in multiple tumours-A real-world multicentric study from India. Int J Cancer 2022; 150 (06) 1045-1052
- 63 Bajpai J, Ventrapati P, Joshi S. et al. Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in India. Breast 2021; 60: 177-184
- 64 Bajpai J, Simha V, Shylasree TS. et al. Pregnancy associated breast cancer (PABC): Report from a gestational cancer registry from a tertiary cancer care centre, India. Breast 2021; 56: 88-95
- 65 Bajpai J, Kagwade S, Chandrasekharan A. et al. “Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia”. Breast 2020; 49: 187-193
- 66 Darby S, McGale P, Correa C. et al; Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011; 378 (9804): 1707-1716
- 67 Clarke M, Collins R, Darby S. et al; Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366 (9503): 2087-2106
- 68 Bartelink H, Horiot JC, Poortmans PM. et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007; 25 (22) 3259-3265
- 69 Polgár C, Major T, Fodor J. et al. Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol 2010; 94 (03) 274-279
- 70 Meattini I, Marrazzo L, Saieva C. et al. Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-Florence trial. J Clin Oncol 2020; 38 (35) 4175-4183
- 71 Bertrand AS, Iannessi A, Natale R. et al. Focused ultrasound for the treatment of bone metastases: effectiveness and feasibility. J Ther Ultrasound 2018; 6 (01) 8
- 72 Tuncali K, Morrison PR, Winalski CS. et al. MRI-guided percutaneous cryotherapy for soft-tissue and bone metastases: initial experience. AJR Am J Roentgenol 2007; 189 (01) 232-239
- 73 Wallace AN, Greenwood TJ, Jennings JW. Use of imaging in the management of metastatic spine disease with percutaneous ablation and vertebral augmentation. AJR AM J Roentgenol 2015; 205 (02) 434-441